Unilever Stock Forecast 2035: Bull, Bear, and Base Case

01. Historical Context

Unilever's past decade argues for realism, not complacency

UL's 10-year adjusted monthly range of $32.63 to $72.50 shows how defensive consumer staples actually behave over full cycles: they can protect capital well, but they rarely sustain extreme valuations without unusually strong mix upgrades or margin surprises. That history is useful because a 2035 forecast should start from what the business has demonstrated, not from an arbitrary terminal price.

Editorial scenario visual for Unilever — Unilever's long-term upside relies on repeatable cash generation and disciplined capital allocation.

Unilever framework across investor time horizons

Horizon	What matters most	What would strengthen the thesis	What would weaken the thesis
2026-2027	Guidance delivery and repurchases	Growth remains in the guided range and buybacks continue	Estimate cuts or weaker volume
2028-2030	Portfolio quality and margin durability	Better mix in Beauty, Wellbeing, and Personal Care	Restructuring drag and low-growth categories holding back returns
2031-2035	Per-share compounding	EPS outgrows revenue through productivity and capital returns	Valuation falls toward low-teens earnings with slower cash growth

The hard numbers today support a disciplined long-term base case. Unilever ended 2025 with EUR50.5 billion of turnover, a 20.0% underlying operating margin, and EUR5.9 billion of free cash flow. Q1 2026 kept the business on a positive volume trajectory. That is enough to support a compounding framework through 2035, but not enough to justify assuming the market will pay a structurally rising multiple every year.

02. Key Forces

The long-term debate is about compounding quality, not headline growth

First, consensus still points to respectable earnings growth. MarketScreener's European-line estimates imply EPS moving from EUR2.59 in 2025 to EUR3.03 in 2026 and EUR3.261 in 2027. That is a healthy short-term bridge, but a 2035 forecast needs to assume growth normalizes after that burst. The realistic question is whether Unilever can hold enough volume, mix, and margin discipline to keep per-share earnings climbing over a decade.

Second, buybacks matter more over a nine-year horizon than a one-year horizon. Management's current EUR1.5 billion repurchase and the disclosed potential for up to EUR6 billion of buybacks between 2026 and 2029 meaningfully improve the long-run per-share path, especially if the stock stays closer to the middle of its historical valuation band rather than the top.

Third, the macro regime is likely to stay less forgiving than the 2010s. The IMF now sees 3.1% global growth in 2026 and 3.2% in 2027, while inflation remains sticky enough to keep the discount-rate debate active. For a defensive stock, that does not destroy the thesis, but it does keep a lid on how much multiple expansion can do for shareholders over time.

Long-term factor scorecard for Unilever

Factor	Current Assessment	Bias	2035 implication
Organic growth quality	Q1 2026 volume up 2.9%; FY2026 guide still positive	Bullish	Supports a steady compounding path if sustained through cycles
Margin profile	2025 underlying operating margin at 20.0%	Neutral to Bullish	Needs to remain around or above 20% to justify long-run upside
Capital returns	Buybacks are active and potentially large through 2029	Bullish	Can materially improve long-run EPS even in a modest growth environment
Valuation starting point	11.15x trailing PE and 15.12x forward PE	Neutral	Allows gains, but does not give the stock a large valuation cushion
Macro regime	Growth is positive, but inflation and rates remain sticky	Neutral to Bearish	Suggests future returns should lean more on earnings than on rerating

The crucial point is that Unilever can still be a good 2035 stock without being a spectacular one. A long stretch of mid-single-digit business growth, selective portfolio pruning, and ongoing share shrink can produce solid shareholder returns even if the valuation multiple only holds steady.

03. Countercase

The long-range bear case is a slow erosion story, not a collapse story

The most realistic bear case is not that Unilever stops making money. It is that growth gradually slows, pricing power normalizes, and investors decide the stock deserves a lower multiple because inflation stays structurally higher and volume growth becomes harder to maintain.

That risk is visible in current data. U.S. CPI is still 3.8%, first-quarter PCE inflation was 4.5%, and euro-area inflation is 3.0%. If that backdrop persists, the market can cap Unilever at a low-to-mid teens earnings multiple even while the company continues to execute reasonably well.

A second risk is that portfolio actions fail to create enough incremental value. The Foods combination with McCormick could sharpen focus, but it also creates stranded-cost and restructuring obligations. If those costs are real while the strategic upside arrives slowly, the stock's long-range upside narrows quickly.

What would turn the 2035 view more cautious

Risk	Latest data point	Current Assessment	Bias
Inflation persistence	U.S. CPI 3.8%, euro-area CPI 3.0%	Still a headwind to long-duration multiples	Bearish
Volume fatigue	Q1 2026 volume rose 2.9%, but the guide floor is only 2%	Healthy now, but worth monitoring	Neutral
Portfolio execution	Foods transaction comes with stranded-cost and restructuring charges	Strategically positive, execution-sensitive	Neutral to Bearish
Valuation reset	Forward PE around 15x is fair, not distressed	Leaves room for compression if growth disappoints	Neutral

A 2035 bear case of $60 to $80 therefore does not require franchise damage. It only requires the market to value Unilever as a stable but slower-growth staples company for most of the next decade.

04. Institutional Lens

Long-term upside depends on what institutions are already signaling

The IMF's April 2026 update tells investors to expect moderate global growth rather than an extraordinary demand backdrop. J.P. Morgan's 2026 outlook adds an important nuance: even if inflation and growth cool, markets can still correct along the way. That combination matters for 2035 because it argues for a choppier road, not for a broken thesis.

Stock-specific consensus also points to moderation rather than exuberance. MarketScreener's analyst set still sees upside from current levels and higher EPS through 2027, while MarketBeat's ADR target band of $60.10 to $71.00 frames the near-term sell-side corridor. A serious 2035 forecast should extend that logic gradually, not extrapolate a short-term target straight into a heroic terminal price.

Institutional anchors for the 2035 view

Source	Updated	What it says	Implication
IMF WEO	April 14, 2026	World growth at 3.1% in 2026 and 3.2% in 2027	Supports a stable-demand but not high-growth backdrop
J.P. Morgan AM	2026 outlook	Growth and inflation should moderate, but volatility remains likely	Long-run holders should expect resets, not a straight line
MarketScreener	May 2026	2026 EPS EUR3.03 and 2027 EPS EUR3.261	Short-term consensus supports a compounding thesis
MarketBeat	May 2026	ADR target range of $60.10 to $71.00	Near-term upside exists, but the sell side is not calling for a huge rerating

The institutional message is consistent: Unilever looks investable as a long-duration quality compounder, but the case rests on repeated operational delivery rather than on one big macro call.

05. Scenarios

2035 price paths with explicit triggers

Because the forecast horizon is long, the scenario ranges matter more than any point estimate. Each path below assumes the current price of $56.24 as the starting anchor and then changes the outcome based on whether Unilever compounds through volume, margin, and capital returns or stalls into a lower multiple.

2035 scenario map for Unilever

Scenario	Probability	Trigger	Target range	Review point
Bull	25%	Volume stays durably above 2%, mix improves in higher-growth categories, and repurchases remain large enough to drive per-share growth	$120 to $145	Reassess after each full-year report, with 2027 the first proof point for whether the stronger EPS path is holding
Base	40%	Sales growth stays around mid-single digits, margins remain close to 20%, and valuation holds around a mid-teens forward multiple	$90 to $115	Review after FY2026 and then every two years against EPS and free-cash-flow delivery
Bear	35%	Inflation stays sticky, growth drifts lower, and the stock trades more like a low-growth staples asset than a premium compounder	$60 to $80	Review if annual volume growth trends below 2% or if valuation compresses below the current long-run band

The base case remains the highest-probability path because Unilever already has the cash generation and category breadth to keep compounding. The limiting factor is that long-run staples returns are usually earned patiently, not explosively.

References